BIOSINO BIO-TEC(08247) major shareholder Chen Peng increased the company's domestic shares by approximately 4.3 million shares.

BIOSINO BIO-TEC (08247) announced that during the period from June 15, 2026 to July 14, the Chairman, President, Executive Director, and major shareholder Mr. Chen Peng, through Jingning GuoKe Health Care Enterprise Management Center (Limited Partnership) and GuoKe Health Innovation Research Institute (Hefei) Partnership Enterprise (Limited Partnership), acquired a total of approximately 10.53 million yuan (acquisition price per share ranging from 2.40 yuan to 2.50 yuan) to purchase a total of approximately 4.3 million shares of the company's domestic shares off-exchange, accounting for approximately 2.97% of the total issued shares of the company. Following the aforementioned increase in shareholdings, as of the date of this announcement, Mr. Chen Peng holds approximately (i) 15.6305 million domestic shares through GuoKe Health Care and GuoKe Health Institute; and (ii) approximately 27.2561 million H shares of the company through HK Zhixin Investment Co., Ltd, totaling approximately 29.64% of the total issued shares (of which domestic shares and H shares account for approximately 19.44% and 42.40% respectively) in each respective category.